Cisplatin in vivo action on lipid content in nuclear matrix from rat kidney cells
Համառոտագիր
The content of total phospholipids and neutral lipids as well as their individual fractions in nuclear matrix preparations from rat kidney cells after in vivo action of the antitumor drug cisplatin was investigated. It was revealed that cisplatin treatment has reduced the total quantity of nuclear matrix phospholipids and neutral lipids by about 25 % and 27 % correspondingly. The diminution of total lipids quantity was accompanied by alterations in quantities of individual fractions of phospholipids and neutral lipids. These data demonstrate the high sensitivity of nuclear matrix lipids metabolism to antitumor drug cisplatin action. It was supposed that the cisplatin antitumor action also can be performed via quantitative changes of internuclear lipids, which are able to regulate the principal functions of cell nuclei.